Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

United States

Georgetown University, Washington D.C., District of Columbia

University of Chicago, Chicago, Illinois

Indiana University, Indianapolis, Indiana

Dana-Farber Cancer Institute, Boston, Massachusetts

University of Pennsylvania, Philadelphia, Pennsylvania

Vanderbilt University, Nashville, Tennessee

University of Washington, Seattle, Washington